Originally published December 2005
Federal Circuit Elaborates on Role of Hatch-Waxman Statute in Preliminary Injunction Analysis
Pfizer, Inc., et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 05-1331
In this November 22, 2005 decision, the Federal Circuit affirmed a New Jersey District Court's grant of a preliminary injunction enjoining defendants Teva Pharmaceuticals USA, Inc., Ranbaxy Pharmaceuticals, Inc. and Ranbaxy Laboratories Limited from infringing U.S. Patent No. 4,743,450 ("the '450 Patent"). The Federal Circuit ruled that the district court correctly found irreparable harm to the patent owner in the absence of the preliminary injunction....
| This service is completely FREE but for the full article and thousands of other articles from 100+ countries please tell us about yourself by registering (and yes, our lawyers like to think you've read our Disclaimer). It only takes 30 seconds and as well as great content you get articles more relevant to you and other advanced features like an optional personalised once-weekly news alert and forward-to-colleague capabilities. We'll also remember your details so you don't have to login again - if you've registered before please login here or if you've forgotten your username click here and we'll remind you. We appreciate your time is important and will respect your privacy - THANK YOU for registering. |
Specific Questions relating to this article should be addressed directly to the author.
 | Do you have a question for the author? |
